Daiwa Securities Group’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
DM
SCM
HA
FBIL
Daiwa Securities Group's LEGN Position: Q1 2026 in Review
Daiwa Securities Group sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 254 shares — an estimated $6K sold.
Daiwa Securities Group first reported a position in LEGN in Q4 2020 and held it in 21 quarters. The position peaked at $356K in Q1 2024. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.
- Daiwa Securities Group reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 254 Legend Biotech shares in Q1 2026, an estimated $6K.
- Daiwa Securities Group first reported a position in Legend Biotech in Q4 2020 and held it in 21 quarters.
- Daiwa Securities Group's Legend Biotech position peaked at $356K in Q1 2024.
- 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.